Related Experiment Video
Updated: Aug 14, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Defects of the apoptotic pathway as therapeutic target against cancer
Tetsuo Mashima1, Takashi Tsuruo
1Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo, Japan.
Abstract:
Over the past 10 years evidence has been accumulating that antitumour agents induce apoptosis in cancer cells and that abnormalities in apoptosis signaling pathways often occur in cancer cells and are associated with drug resistance. The implication is that factors regulating the apoptotic process play a critical role in tumour sensitivity to chemotherapy, and hence may be rational molecular targets for novel antitumour agents. Significantly, oncogenic signals make cancer cells intrinsically more susceptible to apoptosis; defects in the pathway occur subsequent to cancer development. Important emerging questions are the pattern of alterations in the apoptotic pathway in a particular tumour (cell) and the best strategy to exploit them and induce selective tumour cell death. Here, we review recent progress in this field.
Insights
Anticancer drugs trigger apoptosis (programmed cell death) in cancer cells. Understanding apoptosis pathways is key to overcoming drug resistance and developing new cancer therapies.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Accumulating evidence shows anticancer agents induce apoptosis in cancer cells.
- Abnormalities in apoptosis signaling pathways are common in cancer and linked to drug resistance.
- Apoptosis regulators are critical for tumor sensitivity to chemotherapy and potential therapeutic targets.
Purpose of the Study:
- To review recent advancements in understanding apoptosis in cancer.
- To explore strategies for exploiting apoptosis pathways for selective tumor cell death.
- To address the role of oncogenic signals in cancer cell apoptosis susceptibility.
Main Methods:
- Literature review of recent progress in cancer apoptosis research.
- Analysis of evidence on antitumour agents and apoptosis induction.
- Examination of alterations in apoptosis signaling pathways in tumors.
Main Results:
- Anticancer agents effectively induce apoptosis in malignant cells.
- Defects in apoptosis pathways are often acquired during cancer development.
- Oncogenic signals can increase cancer cell susceptibility to apoptosis.
Conclusions:
- Targeting apoptosis pathways offers a rational strategy for novel anticancer agents.
- Identifying specific apoptosis pathway alterations is crucial for effective cancer treatment.
- Exploiting apoptosis mechanisms can lead to selective tumor cell death.
More Related Videos
12:28Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics
Published on: January 11, 2019
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cellular Injury V: Apoptosis and Autophagy
Apoptosis